Financials in USD. Standardized financial statements.
A compact view of how Tenon Medical, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Revenue? | $3.94M | $3.28M | $2.93M | $691,000 | $160,000 | $43,820 | $53,640 |
| Revenue Growth? | +20.4% | +11.9% | +323.7% | +331.9% | +265.1% | -18.3% | 0.0% |
| Cost of Revenue? | $1.59M | $1.57M | $1.69M | $1.33M | $55,000 | $18,257 | $18,257 |
| Gross Profit? | $2.36M | $1.71M | $1.24M | -$641,000 | $105,000 | $25,563 | $35,383 |
| Gross Margin? | +59.8% | +52.2% | +42.4% | -92.8% | +65.6% | +58.3% | +66.0% |
| Operating Expenses? | $15.15M | $15.48M | $16.97M | $18.08M | $6.57M | $561,852 | $568,825 |
| Operating Income? | -$12.79M | -$13.77M | -$15.73M | -$18.73M | -$6.46M | -$536,289 | -$533,440 |
| EBITDA? | -$12.79M | -$12.98M | -$15.13M | -$18.27M | -$6.35M | -$537,519 | -$30 |
| Income Before Tax | -$12.56M | -$13.67M | -$15.58M | -$18.92M | -$7.08M | -$705,365 | -$585,828 |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income? | -$12.56M | -$13.67M | -$15.58M | -$18.92M | -$7.05M | -$585,178 | -$509,580 |
| EPS? | $-1.70 | $-11.26 | $-68.64 | $-187.30 | $-624.38 | $-56.40 | $-49.12 |
| Diluted EPS? | $-1.70 | $-11.26 | $-68.64 | $-187.30 | $-624.38 | $-56.40 | $-49.12 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality